Table 2 Laboratory results of the patients with hereditary transthyretin amyloidosis (n = 16).
From: Emerging multisystem biomarkers in hereditary transthyretin amyloidosis: a pilot study
Subject and sex | hs-TnT (pg/mL) | NT-proBNP (pg/mL) | IVS (mm) | Creatinine (mg/dL) | Cystatin C (mg/L) | eGFR creat (mL/min) | eGFR creat-cyst (mL/min) | GDF-15 (pg/mL) | Umod (ng/mL) |
|---|---|---|---|---|---|---|---|---|---|
M #1 | 20.00 | 1600 | 15 | 0.78 | 0.97 | 93 | 88 | 412.81 | 96.47 |
M #2 | 6.00 | 502 | 18 | 1.42 | 1.24 | 55 | 58 | 671.68 | 28.76 |
M #3 | 0.67 | 440 | 16 | 0.67 | 1.03 | 94 | 85 | 701.54 | 136.99 |
M #4 | 19.34 | 96 | 13 | 0.72 | 0.89 | 95 | 96 | 1042.99 | 72.16 |
M #5 | 0.30 | 337.6 | 10 | 0.97 | 1.24 | 86 | 71 | 959.49 | 48.59 |
M #6 | 2.00 | 500 | 13 | 0.67 | 1.24 | 103 | 77 | 441.15 | 45.23 |
M #7 | 25.00 | 637 | 15 | 0.76 | 1.24 | 97 | 75 | 990.25 | 32.50 |
M #8 | 7.30 | 1420.2 | 19 | 1.02 | 1.12 | 77 | 72 | 1265.41 | 47.27 |
M #9 | 5.00 | 68 | 9 | 0.97 | 0.90 | 93 | 96 | 236.02 | 48.82 |
F #10 | 9.33 | 403.3 | 10 | 0.93 | 1.41 | 70 | 57 | 2112.84 | 26.89 |
M #11 | 5.70 | 53 | 22 | 1.22 | 2.04 | 64 | 42 | 868.19 | 25.77 |
F #12 | 15.70 | 87 | 12 | 1.06 | 1.09 | 55 | 61 | 927.00 | 113.34 |
M #13 | 22.00 | 549 | 15 | 1.37 | 0.80 | 61 | 87 | 573.23 | 127.13 |
F #14 | 31.30 | 101 | 10 | 0.59 | 0.45 | 97 | 124 | 623.16 | 123.43 |
M #15 | 21.00 | 520 | 19 | 1.12 | 1.33 | 67 | 60 | 1552.21 | 35.96 |
M #16 | 6.00 | 639 | 17 | 1.17 | 1.74 | 67 | 49 | 1999.72 | 54.59 |
